KULKARNI SAMARTH

PrivateCIK: 1682019
Location

CAMBRIDGE, MA

KULKARNI SAMARTH (Chief Executive Officer) sold 3.8% of their position (10.02K shares) of CRISPR THERAPEUTICS AG on the open market

Open‑market sale worth $468.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderKULKARNI SAMARTHCIK 1682019
IssuerCRISPR THERAPEUTICS AGCIK 1674416
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+186.10K
Net shares
Net buyer
$468.7K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
215.81K acquired · 29.71K disposed
Non-Derivative Transactions2

Common Shares

Direct
M · Option Exercise

Shares

+19.69K

Price / share

Trade value

% of position

8.0%
3/20/2026
245.83K265.52K

Common Shares

Direct
S · Sale

Shares

10.02K

Price / share

$46.78

Trade value

$468.74K

% of position

3.8%
3/23/2026
265.52K255.50K
Total

Net shares

+9.67K

Net value

-$468.74K

Derivative Transactions3

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Shares

114.25K shares

Shares

+114.25K

Strike price

46.24

Held after

114.25K

Exercisable

3/20/2026

Restricted Stock Units

Direct
A · Award
Converts to

Common Shares

81.88K shares

Shares

+81.88K

Strike price

Held after

81.88K

Exercisable

3/20/2026

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Shares

19.69K shares

Shares

19.69K

Strike price

Held after

39.38K

Exercisable

3/20/2026
KULKARNI SAMARTH — Insider Transaction (Form 4) Filed Mar 24, 2026 | Finecho